Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 12,128 $ 8,485
Cost of revenue 4,372 3,353
Gross profit 7,756 5,132
Research and development costs 4,522 3,379
Sales and marketing expenses 6,715 3,834
General and administrative expenses 4,997 4,082
Operating loss (8,478) (6,163)
Other income (expense):    
Other (expense) income, net (35) 4
Interest income 351 151
Interest expense (1,382) 0
Net loss before income taxes (9,544) (6,008)
Income tax expense 8 18
Net loss $ (9,552) $ (6,026)
Net loss per share attributable to common stockholders:    
Basic (in dollars per share) $ (0.32) $ (0.22)
Diluted (in dollars per share) $ (0.32) $ (0.22)
Weighted average shares outstanding:    
Basic (in shares) 29,546,889 27,718,918
Diluted (in shares) 29,546,889 27,718,918
Product revenue    
Revenue:    
Total revenue $ 8,802 $ 5,291
Service and other revenue    
Revenue:    
Total revenue $ 3,326 $ 3,194